Procurement Summary
Country : USA
Summary : Traveler-Based Genomic Surveillance Program
Deadline : 09 Aug 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 103884658
Document Ref. No. : RFP75D30124R72969
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
The Traveler-based Genomic Surveillance program (TGS) plays an important role in U.S. national biosecurity through its two major goals: (1) early detection of new SARS-CoV-2 variants and other pathogens and (2) filling in gaps in global biosurveillance.
The purpose of TGS is to utilize samples from travelers (clinical and environmental) to test, sequence and monitor trends of SARS-CoV-2 and other important pathogens and public health threats ( e.g. antimicrobial resistance) . TGS is voluntary and enrolls travelers from a wide array of countries. Prioritization of arriving flights is based on factors such as travel volume, geographic region, available sequencing data, disease prevalence and seasonality, etc. TGS is flexible and nimble and maintains the ability to surge capacity depending on public health needs. The de-identified raw data and samples collected belong to CDC. Samples from travelers undergo reverse transcription PCR (RT-PCR) testing and genetic sequencing on all positive samples. The turn-around-time from sample collection to reporting of sequencing results is within 10 days. The program leverages a variety of sampling modalities, including individual testing, pooled testing, wastewater testing, and air sampling. TGS uses a variety of molecular testing techniques and sequencing approaches.
The Traveler-based Genomic Surveillance program (TGS) plays an important role in U.S. national biosecurity through its two major goals: (1) early detection of new SARS-CoV-2 variants and other pathogens and (2) filling in gaps in global biosurveillance.
The purpose of TGS is to utilize samples from travelers (clinical and environmental) to test, sequence and monitor trends of SARS-CoV-2 and other important pathogens and public health threats ( e.g. antimicrobial resistance) . TGS is voluntary and enrolls travelers from a wide array of countries. Prioritization of arriving flights is based on factors such as travel volume, geograph...
Active Contract Opportunity Notice ID RFP75D30124R72969 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier CENTERS FOR DISEASE CONTROL AND PREVENTION Office CDC OFFICE OF ACQUISITION SERVICES
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Jul 09, 2024 12:08 am EDT
Original Date Offers Due: Aug 09, 2024 11:00 am EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: Aug 24, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code: R408 - SUPPORT- PROFESSIONAL: PROGRAM MANAGEMENT/SUPPORT
NAICS Code: 541380 - Testing Laboratories and Services
Place of Performance: USA
Documents
Tender Notice
A19_Solicitation.pdf